🎗We focus our work in research in clinical aspects, biomarkers, cell models, neuroimaging, genetics and genomics of Parkinson’s disease and related parkinsonism
Joined January 2019
- Tweets143
- Following44
- Followers77
- Likes27
Pinned Tweet
Our group will stop publishing tweets directly on social network X and will suspend its accounts in December 2024. This social network has become a platform where they find a sounding board, conspiracy theories and misinformation spread. New account coming at Bluesky @HcpbGroup
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Emerging evidence indicates that sustainable #lifestyle changes—such as increasing physical activity, adopting healthy #diet patterns, and managing stress—can provide symptomatic benefits and potentially slow neurodegeneration in #Parkinson's disease.
Combining these interventions could produce synergistic effects, addressing multiple aspects of the pathophysiology. Despite the challenges of long-term adherence, innovative approaches such as #digital tools and personalised strategies can support sustained lifestyle modifications.
sciencedirect.com/science/ar…
Excited to celebrate the XII Barcelona PPMI Symposium!
🗓️ Oct 16, 2025 | 📍 Aula Magna, Faculty of Medicine (UB)
Together with the Michael J. Fox Foundation, researchers, patients & caregivers join forces to share progress and discuss efforts to stop Parkinson’s disease. 💪🧠
Our study identified pSer106 RAB12 as an endogenous biomarker in easily accessible PBMCs from G2019S carriers and suggests that phospho-/proteomic findings in human PBMCs such as pSer106 RAB12 can be deployed as a universal pharmaco-dynamic readout
medrxiv.org/content/10.1101/…
We found that DRD4 7R+ is a significant genetic risk factor associated with the severity of impulse control disorders in agonist treated PD
onlinelibrary.wiley.com/doi/…
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Potential biomarker identified in clinical samples from #LRRK2-driven Parkinson’s patients using #Curtain and #CurtainPTM. This may be helpful for patient stratification and target engagement in #LRRK2 inhibitor trials. Fantastic #collaboration between @mrcppu and @RFdezSantiago
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Thank you for the opportunity to write an Annual Review of Biochemistry on the Leucine Repeat Protein Kinases - it was a lot of fun putting this together!
annualreviews.org/content/jo…
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Hoy hemos administrado en @hospitalclinic la primera dosis al primer paciente en España del estudio ION717 de @ionispharma, primer ensayo clínico multicéntrico para enfermedades priónicas. La sola materialización de este estudio es todo un hito!! @f_prionicas
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
@MichaelJFoxOrg proposes to use the common pathology in #Parkinsons patients, the aggregated alpha-synuclein identified via a seeding assay, as a "biological definition" of disease and an anchor for integrated staging. Progress or regress? (1/4)
thelancet.com/journals/laneu…
Happy to share our recent paper. We found miRNA levels altered in serum from Parkinson's disease (PD) and LRRK2 premotor non-manifesting carriers (NMC), including a biosignature of conversion of NMC to PD.
pubmed.ncbi.nlm.nih.gov/3673…
Investigadores del Clínic-IDIBAPS buscan voluntarios para obtener información sobre 10.000 personas sanas sin enfermedad de Parkinson, con el objetivo de identificar a los individuos con alto riesgo de desarrollarla en un futuro.
clinicbarcelona.org/noticias…
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Today our team poster on combination of CSF aSYN RT-QuIC, CSF NFL and midbrain/pons MRI planimetry to differentiate degenerative parkinsonisms presented by @CeliaPainous at #mds2022 #MDScongress: great job! 👏🏻
@hospitalclinic
@idibaps
@HcpbGroup
@UBneuroscience
@movedisorder
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Really enjoyed working on this review with Teresa, @BrolinKajsa, @sarabandres1 and other colleagues. Product on the #gp2 #training group @ASAP_Research #Parkinsons
Great work all!! 🤩
onlinelibrary.wiley.com/doi/…
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Thanks to friends and colleagues (Tolosa, Marti, @agrrp) from @hospitalclinic for inviting me to speak about predicting #parkinsons and the @predictpdstudy at their #ppmi annual meeting supported by @MichaelJFoxOrg
Looking forward to collaborating over these next years 🤩
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Our latest teamwork: set-up of CSF aSYN RT-QuIC at @hospitalclinic (now routinely available!) and its combine with CSF NFL & MRI in parkinsonisms @SaludISCIII @la_marato @idibaps @UBneuroscience @mpulidosalgado @ManuStark82 @CeliaPainous @acamaralorenzo
authors.elsevier.com/a/1f5MX…👇🏻
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Estamos buscando neurólog@ para cobertura de verano (1/jun a 30/sept) de sala, interconsultas y guardias @NeurojovenSEN en @hospitalclinic de Barcelona. Si alguien está interesado, por favor, que me contacte.
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
It’has been an amazing experience and good practice for my Viva! Thanks for your support and mentorship. Really glad to be part of the @preventiveneur1
“A 4°C future is incompatible with an organised global community, is likely to go beyond ‘adaptation’, is devastating to the majority of ecosystems and has a high probability of not being stable” – Prof Kevin Anderson;
🎗IDIBAPS/HCPB Parkinson Disease Group retweeted
Les sales de la Fundació Clínic - IDIBAPS estrenen nom
Els treballadors/es de les dues institucions han proposat els noms de científics/ques rellevants que a partir d'ara posaran nom a les diverses sales de reunions
👉ow.ly/Luif50IHfoS
